Abstract
The role of serotonin (5-HT) as a mediator of the endogenous pain control system has been investigated over the last 30 years. Here we review a subset of studies that used electrophysiological techniques to study the mechanisms of action as well as the receptors mediating the spinal effects of serotonin. The works herein discussed employed in vivo or in vitro preparations of control or hyperalgesic animals. According to these reports, 5-HT triggers depressant effects on synaptic transmission limiting the release of neurotransmitters from afferent terminals or the responsiveness of NMDA receptors located in dorsal horn neurones. These mechanisms are most likely mediated by 5-HT1 receptors. In contrast, 5-HT2 receptors seem to mediate excitatory effects such as depolarisation, increased excitability, and neurotransmitter release. The role of 5-HT3 receptors is less clear as they could mediate excitatory or inhibitory effects, depending on variables such as concentration of 5-HT or the state (sensitised/unsensitised) of the spinal cord. The consequences of these spinal effects of serotonin are discussed in the context of pain and analgesia.
Keywords: analgesia, dendrites, dorsal horn neurones, Primary afferent depolarisation (PAD), NMDA transmission
Current Topics in Medicinal Chemistry
Title: Serotonergic Modulation of Spinal Sensory Circuits
Volume: 6 Issue: 18
Author(s): Jose A. Lopez-Garcia
Affiliation:
Keywords: analgesia, dendrites, dorsal horn neurones, Primary afferent depolarisation (PAD), NMDA transmission
Abstract: The role of serotonin (5-HT) as a mediator of the endogenous pain control system has been investigated over the last 30 years. Here we review a subset of studies that used electrophysiological techniques to study the mechanisms of action as well as the receptors mediating the spinal effects of serotonin. The works herein discussed employed in vivo or in vitro preparations of control or hyperalgesic animals. According to these reports, 5-HT triggers depressant effects on synaptic transmission limiting the release of neurotransmitters from afferent terminals or the responsiveness of NMDA receptors located in dorsal horn neurones. These mechanisms are most likely mediated by 5-HT1 receptors. In contrast, 5-HT2 receptors seem to mediate excitatory effects such as depolarisation, increased excitability, and neurotransmitter release. The role of 5-HT3 receptors is less clear as they could mediate excitatory or inhibitory effects, depending on variables such as concentration of 5-HT or the state (sensitised/unsensitised) of the spinal cord. The consequences of these spinal effects of serotonin are discussed in the context of pain and analgesia.
Export Options
About this article
Cite this article as:
Lopez-Garcia A. Jose, Serotonergic Modulation of Spinal Sensory Circuits, Current Topics in Medicinal Chemistry 2006; 6 (18) . https://dx.doi.org/10.2174/156802606778522159
DOI https://dx.doi.org/10.2174/156802606778522159 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Synthesis, Experimental and Computational Studies of N-(4-amino-6-oxo- 1,6-dihydropyrimidin-5-yl)benzamide
Letters in Organic Chemistry Interacting with γSecretase for Treating Alzheimer's Disease: From Inhibition to Modulation
Current Medicinal Chemistry Peripheral Biomarkers to Assess Suicide Risk
Current Psychiatry Reviews Role of Transcranial Doppler Ultrasonography in Cerebrovascular Disease
Recent Patents on CNS Drug Discovery (Discontinued) Structural Properties of Potential Synthetic Vaccine Adjuvants - TLR Agonists
Current Medicinal Chemistry Microglial Store-operated Calcium Signaling in Health and in Alzheimer’s Disease
Current Alzheimer Research Modulation of the Peripheral and Central Inflammatory Responses by a-Melanocyte Stimulating Hormone
Current Protein & Peptide Science Advancements in Devices and Particle Engineering in Dry Powder Inhalation Technology
Current Topics in Medicinal Chemistry Potassium Channels and CNS Diseases
CNS & Neurological Disorders - Drug Targets Kratom and Future Treatment for the Opioid Addiction and Chronic Pain: Periculo Beneficium?
Current Drug Targets Telomere/Telomerase System: A New Target of Statins Pleiotropic Effect?
Current Vascular Pharmacology Resveratrol: A Multifunctional Cytoprotective Molecule
Current Pharmaceutical Biotechnology Gene Frequency of <i>CYP2D6*4</i> and <i>*10</i> Variants in Karachi Population
Current Pharmacogenomics and Personalized Medicine Converging Perturbed Microvasculature and Microglial Clusters Characterize Alzheimer Disease Brain
Current Alzheimer Research A Review Focused on Molecular Mechanisms of Anxiolytic Effect of <i>Valerina officinalis</i> L. in Connection with Its Phytochemistry through <i>in vitro/in vivo</i> Studies
Current Pharmaceutical Design Current Dental Adhesives Systems. A Narrative Review
Current Pharmaceutical Design Interferon alpha for Treatment of Chronic Myeloid Leukemia
Current Drug Targets Computational Biology Tools for Identifying Specific Ligand Binding Residues for Novel Agrochemical and Drug Design
Current Protein & Peptide Science Should the Status of the Pathway Mediated by BRCA1 and BRCA2 be Evaluated Before Selecting Cancer Chemotherapy Drugs?
Current Pharmacogenomics Interferon gama induced Tryptophan Degradation Neuropsychiatric and Immunological Consequences
Current Drug Metabolism